We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Integrated DNA Technologies

For more than 35 years, Integrated DNA Technologies have been enabling genomics laboratories with an oligonucleotide manufacturing process unlike anyone else in the industry, with the most advanced synthesis, modification, purification and quality control capabilities available.

Latest Content

Microscopic rendering of a DNA strand structure fragmenting into smaller molecular components.

IDT and Illumina Streamline Oncology Sequencing Analysis

The collaboration connects IDT’s sequencing library preparation tools with Illumina’s DRAGEN analysis platform to improve efficiency and consistency in cancer genomics studies.

Abstract blue DNA helix with glowing particles in a futuristic genetic science illustration.

Oligo Production Expansion Accelerates Cancer Insights

Expanded manufacturing capacity enables faster, scalable production of customizable oligonucleotides, supporting NGS-based oncology research, MRD applications, and improved assay development.

Abstract illustration of synthetic DNA synthesis with glowing double helix strands.

New Partnership Expands Synthetic DNA Capabilities

An expanded synthetic biology platform enables the assembly of long, high-complexity DNA sequences, reducing technical barriers and supporting next-generation research in medicine, vaccines, and agriculture.

Blue digital screen displaying DNA base sequences representing next-generation sequencing (NGS).

Integrated DNA Technologies and Hamilton Partner To Automate Customizable NGS Workflows and Accelerate Biomarker Discovery

IDT and Hamilton partner to automate NGS workflows, boosting cancer research efficiency and genomic discoveries.

Digital drug capsule with circuit patterns releasing glowing particles, symbolizing AI.

Industry Insight

AI and Synthetic Biology: Balancing Innovation With Biosecurity

AI is revolutionizing biotechnology innovation, but industry stakeholders must work together to mitigate its risks. In this article, Adam Clore explores the role of nucleic acid biosecurity screening tools and how they can be improved.

Sample collection tube with blue cap over a stylized DNA helix and futuristic purple-blue biotech background

HPLC-Purified CRISPR gRNAs

Get more efficient CRISPR editing when HPLC purification and stabilizing modifications are added to your gRNAs. Perfect for more sensitive, pre-clincial editing applications.

An adult holding a baby's hand, signifying the first patient to receive a customized gene therapy was a child.

Industry Insight

How the First Customized Gene Therapy Was Created in Six Months

We spoke with the developers and manufacturers of the CRISPR gene therapy used to treat KJ Muldoon’s rare genetic condition, CPS1, about how the product was created in just six months.

A page with the letters of DNA bases on with a DNA molecule on top.

Integrated DNA Technologies Bolsters Comprehensive Genomic Profiling Solutions With Launch of New Archer™ HRD Technology for Cancer Research

Archer CGP research assays now enable homologous recombination deficiency (HRD) assessment for identification of key biomarkers critical for cancer research.

Double helix structure of DNA.

Integrated DNA Technologies Announces New Licensing Agreement With SeQure Dx To Advance CRISPR-Based Therapeutics

Strategic activation unites best-in-class technology with end-to-end development solutions to optimize therapeutic development process.

Influenza A.

Integrated DNA Technologies Announces New Primers and Probe Set To Identify H5N1 Avian Influenza

PCR/qPCR solution will support surveillance and monitoring of the current H5N1 strain of bird flu in response to multi-state outbreak in U.S. dairy cows.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter